Using Ki-67 to Study Breast Tumors
Author Information
Author(s): V. Kuenen-Boumeester, D.I. Blonk, Th.H. Van der Kwast
Primary Institution: Rotterdam Radio-Therapeutic Institute and Erasmus University
Hypothesis
Can Ki-67 immunocytochemical staining provide better prognostic information about breast tumors compared to traditional methods?
Conclusion
The study found that Ki-67 staining in fine needle aspiration smears can indicate higher proliferative activity in metastatic breast tumors compared to primary tumors.
Supporting Evidence
- The study found that benign tumors had a low percentage of Ki-67 positive nuclei, while malignant tumors had significantly higher percentages.
- Metastatic tumors showed even higher Ki-67 levels compared to primary tumors.
- Previous studies indicated that Ki-67 levels could be related to the aggressiveness of breast cancer.
Takeaway
Researchers looked at breast tumors and found that a special stain called Ki-67 can help show how fast the cancer cells are growing, especially in tumors that have spread.
Methodology
The study used fine needle aspiration smears from various breast tumors and applied Ki-67 immunocytochemical staining to assess the percentage of proliferating cells.
Limitations
The number of investigated tumors was too low to establish clear relationships between tumor size, menopausal status, and Ki-67 levels.
Participant Demographics
The study included 38 patients with primary breast carcinomas, with a breakdown of premenopausal and postmenopausal status.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website